About Us

Corhythm is an early stage company developing a novel therapy for the treatment of atrial fibrillation.

The approach and technology for Corhythm was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur and investor. For more information, please go to www.incubelabs.com.